BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3978170)

  • 21. Effects of bipolar affective disorder and lithium administration on the cholinergic system in human blood.
    Jope RS; Wright SM; Walter-Ryan WG; Alarcon RD
    J Psychiatr Res; 1986; 20(1):9-18. PubMed ID: 3712294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red cell choline in spasmodic torticollis and in a monozygotic twin pair with Tourette's syndrome.
    Lal S; Gauthier S; Wood PL; Kiely ME; Waserman J; Vasavan Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):785-9. PubMed ID: 2293256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decay in plasma lithium and normalization in red blood cell choline following cessation of lithium treatment in two elderly individuals with Alzheimer-type dementia.
    Pomara N; Block R; Domino EF; Gershon S
    Biol Psychiatry; 1984 Jun; 19(6):919-22. PubMed ID: 6430359
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies.
    Davis BM; Mohs RC; Greenwald BS; Mathé AA; Johns CA; Horvath TB; Davis KL
    J Am Geriatr Soc; 1985 Nov; 33(11):741-8. PubMed ID: 2414354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility.
    Peña-Bautista C; Flor L; López-Nogueroles M; García L; Ferrer I; Baquero M; Vento M; Cháfer-Pericás C
    Clin Chim Acta; 2020 Jan; 500():233-240. PubMed ID: 31678274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia.
    Ihara Y; Hayabara T; Sasaki K; Fujisawa Y; Kawada R; Yamamoto T; Nakashima Y; Yoshimune S; Kawai M; Kibata M; Kuroda S
    J Neurol Sci; 1997 Dec; 153(1):76-81. PubMed ID: 9455982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of lipophilic fluorescent products in blood of Alzheimer's disease patients.
    Chmátalová Z; Vyhnálek M; Laczó J; Hort J; Skoumalová A
    J Cell Mol Med; 2016 Jul; 20(7):1367-72. PubMed ID: 26991927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease.
    Lövheim H; Elgh F; Johansson A; Zetterberg H; Blennow K; Hallmans G; Eriksson S
    Alzheimers Dement; 2017 Jul; 13(7):778-782. PubMed ID: 28073031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease.
    Pomara N; Domino EF; Yoon H; Brinkman S; Tamminga CA; Gershon S
    J Clin Psychiatry; 1983 Aug; 44(8):293-5. PubMed ID: 6874650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma, red cell, and cerebrospinal fluid folate in Alzheimer's disease].
    Abalan F; Zittoun J; Boutami C; Dugrais G; Manciet G; Decamps A; Antoniol B
    Encephale; 1996; 22(6):430-4. PubMed ID: 10901835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane modifications of red blood cells in Alzheimer's disease.
    Sabolovic D; Roudier M; Boynard M; Pautou C; Sestier C; Fertil B; Geldwerth D; Roger J; Pons JN; Amri A; Halbreich A
    J Gerontol A Biol Sci Med Sci; 1997 Jul; 52(4):B217-20. PubMed ID: 9224427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplex immunoassay measurement of amyloid-β
    Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
    Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
    Vishnu VY; Modi M; Sharma S; Mohanty M; Goyal MK; Lal V; Khandelwal N; Mittal BR; Prabhakar S
    PLoS One; 2016; 11(11):e0166369. PubMed ID: 27861589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic processes in blood samples from patients with major psychiatric disorders.
    Jope RS; Walter-Ryan WG; Alarcon RD; Lally KM
    Biol Psychiatry; 1985 Dec; 20(12):1258-66. PubMed ID: 4063416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia.
    Pascual J; Fontán A; Zarranz JJ; Berciano J; Flórez J; Pazos A
    Brain Res; 1991 Jun; 552(1):170-4. PubMed ID: 1913175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential electrophoretic behavior in aqueous polymer solutions of red blood cells from Alzheimer patients and from normal individuals.
    Walter H; Widen KE
    Biochim Biophys Acta; 1995 Mar; 1234(2):184-90. PubMed ID: 7535101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choline chloride fails to improve cognition of Alzheimer's disease.
    Thal LJ; Rosen W; Sharpless NS; Crystal H
    Neurobiol Aging; 1981; 2(3):205-8. PubMed ID: 7312098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RBC choline and renal disorders during lithium treatment.
    Gutterman DF; Correa EI; DePaulo JR; Coyle JT
    Am J Psychiatry; 1985 Apr; 142(4):493-5. PubMed ID: 3976925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review and meta-analysis of the circulatory, erythrocellular and CSF selenium levels in Alzheimer's disease: A metal meta-analysis (AMMA study-I).
    Reddy VS; Bukke S; Dutt N; Rana P; Pandey AK
    J Trace Elem Med Biol; 2017 Jul; 42():68-75. PubMed ID: 28595794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.